2014 Q4/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Biogen Idec
7.9
2 +0 Kyowa Hakko Kirin UK
7.2
3 +5 Actelion UK
7.2
4 -1 Cytogen
7.1
5 +0 Otsuka Pharmaceuticals Europe
7.0
6 +36 Debiopharm
7.0
7 +3 Galenica AG
6.7
8 +3 Taisho Pharmaceutical
6.6
9 +16 Diffusion Pharmaceuticals
6.4
10 -6 Kyorin Holdings
6.4
11 +5 Meda Pharmaceuticals
6.4
12 -3 Kaken Pharmaceutical
6.4
13 -1 Vectura
6.4
14 +0 United Therapeutics
6.3
15 +37 Lundbeck
6.3
16 -10 EISAI UK
6.0
17 -4 Otsuka Pharmaceuticals
6.0
18 +2 Actelion
5.9
19 -1 EISAI
5.9
20 -5 Recordati
5.9
21 -14 Wockhardt
5.8
22 -8 Genmab
5.7
23 -1 Bavarian Nordic
5.7
24 +0 Ipsen UK
5.7
25 +6 Covence
5.6
26 +2 Mitsubishi Tanabe Pharma Europe Ltd
5.6
27 +46 Gruenenthal
5.5
28 -7 Genzyme UK
5.4
29 +0 Daiichi-Sankyo UK
5.4
30 +0 Valeant Europe
5.4
31 -8 Medivation
5.3
32 +26 Alfa Wassermann
5.3
33 -7 Santen
5.3
34 -1 Servier
5.2
35 -1 Yakult UK
5.2
36 +72 CinnaGen
5.2
37 +11 Zandu
5.1
38 +0 Akorn
5.1
39 -12 Dainippon Sumitomo
5.1
40 -8 Valeant Pharmaceuticals
5.1
41 +42 Kissei
5.0
42 -7 Dusa Pharmaceuticals
5.0
43 +4 Stallergenes UK
5.0
44 +17 Nippon Kayaku
5.0
45 -15 Nippon Chemiphar
5.0
46 -9 Boehringer Ingelheim
4.9
47 -8 MediGene
4.8
48 +3 Vitrolife
4.8
49 -6 Sanofi UK
4.8
50 -6 Galderma
4.8


Changes in rank are compared to 2014 Q3/Global Life Sciences. Since then, 9 sites entered the survey, 4 sites left the survey and 45 sites could not be included in the rankings (6 fewer since last time). Build your own. Report statistics.